Decode Health secures $1.9 million NIH Phase II SBIR award for its AI-driven multiple sclerosis biomarker program, advancing research in collaboration with Circular Genomics.
Decode Health, alongside Circular Genomics, has announced a research initiative focused on circular RNAs in multiple sclerosis. They are leveraging Decode's NIH-funded MS biomarker program and Circular Genomics' RNA platform to enhance detection and monitoring. This collaboration aims to develop specific circRNA signatures to improve early disease detection. The initiative is anchored by a $1.9 million grant from the NIH.
Company Information
Company
Decode Health
Location
Nashville, Tennessee, United States
About
Decode Health is a precision medicine R&D company based in Nashville, TN. The company's platform integrates automated multiomics and clinical analytics with proprietary patient data to enhance biomarker discovery. It has extensive research experience in coding and non-coding RNA biology, focusing on the development of AI-driven biomarker programs for various diseases. Decode Health is particularly invested in advancing applications in multiple sclerosis through its NIH-funded projects.
Fundz sees it the moment Decode Health raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
NashvilleBiotechnologyHealth CareArtificial IntelligenceGeneticsHealth Diagnostics